ESR1 and breast cancer: Unlike MDA-MB-231 cells, ER+ bone-tropic breast cancer cells could produce exosomal miR-19a, which promotes osteoclastogenesis and bone metastasis by suppressing PTEN expression and inducing NF-κB and AKT pathways [41].